---
figid: PMC4324503__nihms654071f5
figtitle: Pharmacological modulation of the AKT/microRNA-199a-5p/CAV1 pathway ameliorates
  cystic fibrosis lung hyper-inflammation
organisms:
- Mus musculus
- Rattus norvegicus
- Armoracia rusticana
- Malus domestica
- Homo sapiens
- Oryctolagus cuniculus
- Pseudomonas aeruginosa
- murine stem cell retroviral vector
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Oryctolagus cuniculus
- Drosophila melanogaster
pmcid: PMC4324503
filename: nihms654071f5.jpg
figlink: /pmc/articles/PMC4324503/figure/F5/
number: F5
caption: TLR4 activation induces the PI3K-AKT pathway in MΦs, which down-regulates
  microRNA miR-199a-5p, allowing expression of CAV-1 and subsequent negative feedback
  on the TLR4 pro-inflammatory cascade (NF-kB/MAPK signaling). In absence of functional
  CFTR, MΦs have a blunted PI3K/pAKT signaling in response to TLR4 activation, which
  leads to accumulation of miR-199a-5p. Increased levels of miR-199a-5p, targeting
  the 3′-UTR of CAV1, interfere with induction of CAV1 in response to inflammatory
  triggers, ultimately leading to ineffective negative feedback of TLR4 signaling
  and hyper-inflammation. Celecoxib stimulates the AKT/miR-199a-5p/CAV1 pathway in
  CF murine and human MΦs, and decreases lung hyper-inflammation in Cftr-deficient
  mice.
papertitle: Pharmacological modulation of the AKT/microRNA-199a-5p/CAV1 pathway ameliorates
  cystic fibrosis lung hyper-inflammation.
reftext: Ping-xia Zhang, et al. Nat Commun. 2015;6:6221-6221.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9096726
figid_alias: PMC4324503__F5
figtype: Figure
redirect_from: /figures/PMC4324503__F5
ndex: 9ead11b9-de9f-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4324503__nihms654071f5.html
  '@type': Dataset
  description: TLR4 activation induces the PI3K-AKT pathway in MΦs, which down-regulates
    microRNA miR-199a-5p, allowing expression of CAV-1 and subsequent negative feedback
    on the TLR4 pro-inflammatory cascade (NF-kB/MAPK signaling). In absence of functional
    CFTR, MΦs have a blunted PI3K/pAKT signaling in response to TLR4 activation, which
    leads to accumulation of miR-199a-5p. Increased levels of miR-199a-5p, targeting
    the 3′-UTR of CAV1, interfere with induction of CAV1 in response to inflammatory
    triggers, ultimately leading to ineffective negative feedback of TLR4 signaling
    and hyper-inflammation. Celecoxib stimulates the AKT/miR-199a-5p/CAV1 pathway
    in CF murine and human MΦs, and decreases lung hyper-inflammation in Cftr-deficient
    mice.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CFTR
  - TLR4
  - AKT1
  - AKT2
  - AKT3
  - NFKB1
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CAV1
  - HMOX1
  - Cftr
  - Tlr4
  - Akt1
  - Nfkb1
  - Cav1
  - Hmox1
  - mo
  - cf
  - Toll-4
  - Akt
  - Dif
  - dl
  - Rel
  - MKP-4
  - p38b
  - rl
  - Ho
---
